1-20 of 205
Mehdi Hamadani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.

Available to Purchase
Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, Jinalben Patel, Luca Castagna, Emanuele Angelucci, Herve Finel, Alexander D. Kulagin, Bertram Glass, Paolo Corradini, Alex F. Herrera, Didier Blaise, Mohamed A Kharfan-Dabaja, Khalid Halahleh, Sairah Ahmed, Carmen Martinez, Sebastian Giebel, Silvia Montoto, Richard J. Jones, Nausheen Ahmed, Ryan C Lynch, Marcos J de Lima, Mazyar Shadman, Craig S. Sauter, Kwang Woo Ahn, Mehdi Hamadani, Ali Bazarbachi, Anna Sureda
Journal: Blood
Blood blood.2024027197.
https://doi.org/10.1182/blood.2024027197
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma

Available to Purchase
Clinical Trials & Observations Brief Report
Laura Samples, Hossein Sadrzadeh, Matthew J. Frigault, Caron A. Jacobson, Mehdi Hamadani, Ashwath Gurumurthi, Paolo Strati, Roni Shouval, Ariela Noy, Peter A. Riedell, Saurabh Dahiya, David G. Maloney, Brian G. Till, Alexandre V. Hirayama, Jordan Gauthier, Ajay K. Gopal, Stephen D. Smith, Christina Poh, Ryan Lynch, Chaitra Ujjani, Mengyang Di, Vikram Raghunathan, Mehrdad Shakib-Azar, Kikkeri N. Naresh, Ted A. Gooley, Jean Yared, Michael D. Jain, Frederick L. Locke, Lori Ann Leslie, Narendranath Epperla, Monalisa Ghosh, Alan Skarbnik, Brian T. Hill, Manali K. Kamdar, Valentin Ortiz-Maldonado, Nuria Martinez-Cibrian, Leyla Shune, Mazyar Shadman
Journal: Blood
Blood (2025) 145 (23): 2762–2767.
https://doi.org/10.1182/blood.2024026831
Published: 2025
Includes: Supplemental data
Journal Articles

Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AML

Open Access
Clinical Trials & Observations
Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K. Singh, Mark R. Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L. Uy, Edmund K. Waller, Sumithira Vasu, Melhem Solh, Asmita Mishra, Lori S. Muffly, Hee-Je Kim, Matthias Stelljes, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Caroline Chen, Nahla Hasabou, Matt Rosales, Jason Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi-Bin Chen
Journal: Blood
Blood (2025) 145 (19): 2138–2148.
https://doi.org/10.1182/blood.2024025154
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based Graft Versus Host Disease Prophylaxis

Free
Moazzam Shahzad, Aleenah Mohsin, Muhammad Kashif Amin, Aqeeb Ur Rehman, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Mohammad Ammad Ud Din, Leyla O. Shune, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood
Blood (2024) 144 (Supplement 1): 2118.
https://doi.org/10.1182/blood-2024-199442
Published: 2024
Journal Articles

Outcomes of Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis in Elderly Patients over 70 Years of Age with Acute Leukemia and Myelodysplastic Syndromes

Free
Muhammad Umair Mushtaq, Amir Kasaeian, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Naghmeh Khavandgar, Hediyeh Alemi, Muhammad Fareed Khalid, Iqra Anwar, Matthew McGuirk, Al-Ola Abdallah, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood
Blood (2024) 144 (Supplement 1): 3543.
https://doi.org/10.1182/blood-2024-201164
Published: 2024
Journal Articles

Factors Associated with Acute and Chronic Graft-Versus-Host Disease after Matched Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GvHD Prophylaxis

Free
Moazzam Shahzad, Aqeeb Ur Rehman, Muhammad Kashif Amin, Aleenah Mohsin, Sibgha Gull Chaudhary, Iqra Anwar, Jawad Noor, Rajat Bansal, Matthew McGuirk, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood
Blood (2024) 144 (Supplement 1): 2147.
https://doi.org/10.1182/blood-2024-199533
Published: 2024
Journal Articles

Impact of Conditioning Intensity on Outcomes after Allogeneic Related Donor HCT with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis in Acute Leukemia and Myelodysplastic Syndromes

Free
Muhammad Umair Mushtaq, Amir Kasaeian, Muhammad Kashif Amin, Aqeeb Ur Rehman, Naghmeh Khavandgar, Hediyeh Alemi, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Haitham Abdelhakim, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood
Blood (2024) 144 (Supplement 1): 2141.
https://doi.org/10.1182/blood-2024-199413
Published: 2024
Journal Articles

Impact of Minimal Residual Disease Status on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Free
Moazzam Shahzad, Sohaib Irfan, Muhammad Kashif Amin, Muhammad Jawad Javed, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Zobia Farooq, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood
Blood (2024) 144 (Supplement 1): 3552.
https://doi.org/10.1182/blood-2024-193477
Published: 2024
Journal Articles

Factors Associated with Graft-Versus-Host Disease after Related Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Free
Muhammad Umair Mushtaq, Amir Kasaeian, Muhammad Kashif Amin, Hediyeh Alemi, Naghmeh Khavandgar, Aqeeb Ur Rehman, Sibgha Gull Chaudhary, Matthew McGuirk, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood
Blood (2024) 144 (Supplement 1): 3517.
https://doi.org/10.1182/blood-2024-199559
Published: 2024
Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Free
Sibgha Gull Chaudhary, Moazzam Shahzad, Kayla Pfannenstiell, Muhammad Kashif Amin, Amir Kasaeian, Naghmeh Khavandgar, Hediyeh Alemi, Sohaib Irfan, Matthew McGuirk, Syed Nasir Abbas Bukhari, Anurag K. Singh, Mehdi Hamadani, Muhammad Umair Mushtaq
Journal: Blood
Blood (2024) 144 (Supplement 1): 2122.
https://doi.org/10.1182/blood-2024-202260
Published: 2024
Journal Articles

Impact of CD34+ Graft Cell Dose on Outcomes after Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

Free
Sibgha Gull Chaudhary, Moazzam Shahzad, Amir Kasaeian, Muhammad Fareed Khalid, Muhammad Kashif Amin, Naghmeh Khavandgar, Hediyeh Alemi, Matthew McGuirk, Kayla Pfannenstiell, Syed Nasir Abbas Bukhari, Sunil Abhyankar, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood
Blood (2024) 144 (Supplement 1): 3503.
https://doi.org/10.1182/blood-2024-201994
Published: 2024
Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Matched Sibling Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based Gvhd Prophylaxis

Free
Muhammad Umair Mushtaq, Amir Kasaeian, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Hediyeh Alemi, Naghmeh Khavandgar, Iqra Anwar, Sohaib Irfan, Matthew McGuirk, Al-Ola Abdallah, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood
Blood (2024) 144 (Supplement 1): 2119.
https://doi.org/10.1182/blood-2024-200031
Published: 2024
Journal Articles

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

Free
Matthew Hamby, Brian Egleston, Zachary AK Frosch, Raphael E. Steiner, Ariela Noy, Veronica Carvajal, Seda S. Tolu, Gaston Jean-Louis, Jennifer E. Amengual, Romil Patel, Sairah Ahmed, Timothy Voorhees, Robert Baiocchi, Andres Ramirez-Gamero, Jorge J. Castillo, Emily Hamburger, Christopher Dittus, Imran A. Nizamuddin, Neha Mehta-Shah, Nyein Nyein Thaw Dar, Jose Sandoval-Sus, Alexandra E. Rojek, Peter A. Riedell, Vinod Solipuram, Paul G. Rubinstein, Anthony Ariotti, Gita Suneja, Alexander Vartanov, Charles Milrod, Adam J. Olszewski, Gordon Smilnak, Emily Ayers, Sahaj Desai, Joanna M. Rhodes, Gabriella Magarelli, Tatyana Feldman, Meredith Pellon, David M. Aboulafia, William Bae, Carlos Galvez, Vineel Bhatlapenumarthi, Mehdi Hamadani, Stefan K. Barta
Journal: Blood
Blood (2024) 144 (Supplement 1): 573.
https://doi.org/10.1182/blood-2024-198008
Published: 2024
Journal Articles

Glofitamab in Combination with Rituximab Plus Ifosfamide, Carboplatin, and Etoposide Shows Favorable Efficacy and Manageable Safety in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Eligible for Stem Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: Results from a Phase Ib Study

Free
Catherine S. Diefenbach, Paolo F. Caimi, Nakhle S Saba, Fernando Vargas Madueno, Mehdi Hamadani, Luis E. Fayad, Peter A. Riedell, Andrew Gillis-Smith, Stephen Simko, Victor Orellana-Noia, Maria Filippou-Frye, Amy V. Kapp, James Relf, Linda Lundberg, Lauren C. Pinter-Brown
Journal: Blood
Blood (2024) 144 (Supplement 1): 987.
https://doi.org/10.1182/blood-2024-198452
Published: 2024
Journal Articles

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) As Second-Line (2L) Therapy in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): First Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Free
Maria Silvina Odstrcil Bobillo, Swetha Kambhampati, Dasom Lee, Bradley D. Hunter, Ogechukwu Egini, Krish Patel, Patrick M. Reagan, David Bernasconi, Soyoung Kim, Charimar Santiago Parrilla, Tracy Krimmel, Fei Fei Liu, Debasmita Roy, Sairah Ahmed, Jennifer L. Crombie, Saurabh Dahiya, Mehdi Hamadani, Catherine J. Lee, Marcelo C. Pasquini, Mazyar Shadman, Alex F. Herrera, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 470.
https://doi.org/10.1182/blood-2024-199723
Published: 2024
Journal Articles

Single-Agent Ibrutinib Versus Allogeneic Hematopoietic Cell Transplantation for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and del(17p)

Free
Farrukh T. Awan, Ran Liu, Hsin-Hui Huang, Matthew Bye, Kwang Wooahn, Gabriel S. Krigsfeld, Anat Raz, Heather R Wolfe, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 2178.
https://doi.org/10.1182/blood-2024-194156
Published: 2024
Journal Articles

Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis

Free
Sameem Abedin, Qinghua Lian, Michael J Martens, MHD Monzr M. Al Malki, Hany Elmariah, Mahasweta Gooptu, Karilyn T. Larkin, Brian C. Shaffer, Alison W Loren, Melhem M. Solh, Amin M. Alousi, Omer Jamy, Janny M. Yao, Kristy Applegate, Miguel Angel Perales, Leslie Kean, Yvonne A. Efebera, Ran Reshef, William Clark, Eric Leifer, Mary M. Horowitz, Richard J. Jones, Javier Bolanos-Meade, Shernan G. Holtan, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 1042.
https://doi.org/10.1182/blood-2024-193827
Published: 2024
Journal Articles

Early Safety and Feasibility Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for Gvhd Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Free
Sameem Abedin, Fateeha Furqan, Lyndsey Runaas, Walter Longo, Nirav N. Shah, Timothy S. Fenske, Marcelo C. Pasquini, William R Drobyski, Xue-Zhong Yu, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 1039.
https://doi.org/10.1182/blood-2024-200832
Published: 2024
Journal Articles

Real-World Early Outcomes of Second-Line Axicabtagene Ciloleucel (Axi-Cel) Therapy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Free
Dasom (Caroline) Lee, Swetha Kambhampati, Maria Silvina Odstrcil Bobillo, Babatunde Adedokun, Mazyar Shadman, Amanda L. Olson, Alex F. Herrera, Catherine J. Lee, Caron A. Jacobson, Matthew Bye, Mehdi Hamadani, Soyoung Kim, Saurabh Dahiya, Zhen-Huan Hu, Kelly Speth, Christina To, Debbie L. Mirjah, Timothy Best, Frederick L. Locke, Nausheen Ahmed, Michael T. Tees, Marcelo C. Pasquini, Sairah Ahmed
Journal: Blood
Blood (2024) 144 (Supplement 1): 526.
https://doi.org/10.1182/blood-2024-199139
Published: 2024
Journal Articles

Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM)

Free
Kritika Yadav, Tanvi H. Patel, Ramya Bachu, Jean Esselmann, Lisa E Rein, Aniko Szabo, Abhishek Janardan, Evanka Annyapu, Catherine E. Skoog, Areyl Goff, Othman Salim Akhtar, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N. Shah, Frits van Rhee, Mehdi Hamadani, Binod Dhakal, Anita D'Souza, Meera Mohan, Carolina Schinke
Journal: Blood
Blood (2024) 144 (Supplement 1): 254.
https://doi.org/10.1182/blood-2024-210725
Published: 2024